Contribution of Bcl-2, but not Bcl-xl and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells

Hypertension

Volumn 37, Issue 5, 2001, Pages 1341-1348

  Yamamoto, Kei ^a   Morishita, Ryuichi ^a   Hayashi, Shin Ichiro ^a   Matsushita, Hidetsugu ^a   Nakagami, Hidenori ^a   Moriguchi, Atsushi ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Kaneda, Yasufumi ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Blood vessels; Growth substances; Hypoxia; Vascular diseases

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SCATTER FACTOR;

ANGIOGENESIS; ARTICLE; CELL COUNT; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPOXIA; MOLECULAR DYNAMICS; PRIORITY JOURNAL;

EID: 0035714568     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.5.1341     Document Type: Article

References (50)

1. Mechanisms of angiogenesis
2. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
3. In vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth factor molecule promotes angiogenesis
4. Autocrine-paracrine effects of over-expression of hepatocyte growth factor gene on growth of endothelial cells
5. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor
6. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure
7. Aortic smooth muscle cells express and secrete vascular endothelial growth factor
8. Expression of local hepatocyte growth factor system in vascular tissues
9. Human vascular permeability factor: Isolation from U937 cells
10. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
11. The emerging concept of vascular remodeling
12. Angiogenesis in skeletal and cardiac muscle
13. Actions of hepatocyte growth factor as a local modulator in the kidney: Potential role in pathogenesis of renal disease
14. Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cells
15. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes
16. Role of hepatocyte growth factor in endothelial regulation: Prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor
17. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation
18. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms
19. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: Balance between growth and death signals
20. Growth factor-induced modulation of endothelin-1 binding to human smooth-muscle cells
21. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
22. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
23. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium
24. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet
25. Serum deprivation induced apoptosis accompanied by up-regulation of p53 and bax in human aortic vascular smooth muscle cells
26. Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen
27. Molecular cloning and expression of human hepatocyte growth factor
28. Role of ICE-like proteases in endothelial cell hypoxic and reperfusion injury
29. Induction of apoptosis at different oxygen tensions: Evidence that oxygen radicals do not mediate apoptotic signaling
30. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
31. Bcl-2 and the regulation of programmed cell death
32. Immediate early up-regulation of bax expression by p53 but not TGF β1: A paradigm for distinct apoptotic pathways
33. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system
34. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
35. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
36. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
37. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
38. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
39. Vascular endothelial growth factor administration in chronic myocardial ischemia
40. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as "cytokine supplement therapy"
41. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
42. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
43. Ischemic tissue injury
44. Cytosol-to-membrane redistribution of bax and bcl-xL during apoptosis
45. Hepatocyte growth factor: A multifunctional cytokine
46. Many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis
47. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity
48. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
49. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
50. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: Down-regulation of HGF in response to hypoxia in vascular cells